news – Page 170 – pharmaceutical daily

April 29, 2025 Off

Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion

Reflects business philosophy of commercial success through patient accessibilityRecently executed agreement with CD 8 Technology Services LLC providing up to…

April 29, 2025 Off

Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

By GlobeNewswire

Prolonged duration of response, deep B-cell depletion, and well-tolerated safety profile support the potential of AlloNK® + rituximab for the…

April 29, 2025 Off

Arbor Biotechnologies to Present Foundational Data for PH1 and CNS Programs at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

By GlobeNewswire

– Oral presentation to include preclinical data supporting the clinical advancement of ABO-101 for the treatment of primary hyperoxaluria type 1…

April 29, 2025 Off

Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting

By GlobeNewswire

CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced…

April 29, 2025 Off

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

By GlobeNewswire

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics…

April 29, 2025 Off

Spur Therapeutics Announces Oral and Poster Presentations Highlighting Data from Clinical and Preclinical Programs at Upcoming ASGCT Annual Meeting

By GlobeNewswire

LONDON, April 28, 2025 (GLOBE NEWSWIRE) — Spur Therapeutics today announced that it will share new data from its gene…

April 29, 2025 Off

Axovia Therapeutics Announces Three Upcoming Poster Presentations at ASGCT

By GlobeNewswire

LONDON, April 28, 2025 (GLOBE NEWSWIRE) — Axovia Therapeutics Ltd., a biotechnology company developing therapies to address the genetic causes…

April 29, 2025 Off

Shape Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting

By GlobeNewswire

Data support potential of innovative gene therapy using novel RNA editing, paired with targeted AAV.ai delivery and scalable manufacturing platformsSEATTLE,…

April 29, 2025 Off

Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting

By GlobeNewswire

PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) — Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent…

April 29, 2025 Off

CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting

By GlobeNewswire

Preclinical data to showcase the potential of regRNA-targeting to increase protein levels in a clinically meaningful way by upregulating gene…